Two studies reported that MRPS23 knockdown in breast cancer cells suppressed proliferation, metastasis, and invasion while promoting apoptosis and increasing sensitivity to paclitaxel [70,71]. This evidence concerns the gene MRPS23 and breast carcinoma.